Quantcast
Home / News Story / State's decision to go it alone on Zyprexa nets tenfold increase (access required)

State's decision to go it alone on Zyprexa nets tenfold increase (access required)

A display of determination to take pharmaceutical giant Eli Lilly and Co. to trial helped South Carolina negotiate a $45 million settlement over its claims that the company engaged in fraudulent prescription marketing of the anti-psychotic drug Zyprexa. The settlement, which Attorney General Henry McMaster announced Oct. 23, was the state's second biggest ever. Only its ...

Leave a Reply

Your email address will not be published. Required fields are marked *

*